Delivery Order SPE2DX15D8002-SPE2DX24F2VX4

Award Date 4/16/24
Potential Completion Date 4/17/24
Potential Value $11K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $10,586.33, is for the provision of Stelara 90 mg/mL syringes, which are a biologic medication used to treat autoimmune conditions. The contract has an ultimate completion date of June 18, 2024 and was awarded on June 17, 2024. This...
This is a $8,546.68 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the supply of Stelara 90 mg/mL syringes, a biologic drug used to treat autoimmune conditions. There is no set-aside designation for this contract. Dakota Drug, Inc. has over 20 years of experience as a prime contractor to the DLA, providing a wide range of pharmaceutical products, medical supplies,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $33,222.66 and a period of performance through May 16, 2024. The award does not utilize a set-aside designation. Dakota Drug, Inc. is an experienced prime...
This is a $12,846.67 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of Stelara 90 mg/mL syringes. The contract has no set-aside designation and is awarded under DLA's pharmaceutical supply chain contracts to support medical supply operations for the U.S. Armed Forces. Dakota Drug, Inc. is an experienced prime contractor to DLA, specializing in providing a wide range of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Stelara 90 mg/mL syringes, with a completion date of November 2, 2023, and a ceiling value of $8,600.28. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense. The company holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense, to the prime contractor Dakota Drug, Inc. The $9,826.08 firm fixed-price delivery order covers the supply of STELARA 90 MG/ML syringes, a biologic drug used to treat autoimmune conditions. The contract has a period of performance through May 30, 2024. Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit subchapter S...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the supply of STELARA 90 MG/ML SYRINGE, a pharmaceutical product, with a potential value of $9,470.54 and a completion date of January 9, 2024. The contract was not set aside for any specific business designation. This delivery order is...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of STELARA 90 MG/ML SYRINGEML. The $11,087.94 contract has a completion date of March 21, 2024 and does not utilize a set-aside. Dakota Drug, Inc. has over two decades of experience providing a wide range of pharmaceutical products and medical supplies to support the DLA Troop Support Medical's mission of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The $8,388.98 contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a period of performance through March 29, 2024. This contract does not have a set-aside designation. Dakota Drug, Inc. is an experienced prime contractor to the DLA Troop Support Medical, having provided a...
This is a $18,921.34 firm fixed-price delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) for the provision of Stelara 90 mg/mL syringes. The contract has an ultimate completion date of July 10, 2024 and does not have a set-aside designation. Dakota Drug, Inc. is an experienced prime contractor to the DLA, supplying a wide range of pharmaceutical products, medical supplies, and healthcare equipment in...
  • SPE2DX15D8002
    Indefinite Delivery Contract
  • SPE2DX15D8002-SPE2DX24F2VX4
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Dakota Drug, Inc. The contract is for the supply of Stelara 90 mg/ml syringes, a biologic medication used to treat autoimmune conditions. The contract has a ceiling value of $10,534.93 and a period of performance through April 17, 2024. Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit Subchapter S corporation and has been providing pharmaceutical products and medical supplies to the U.S. Armed Forces for over two decades through prime federal contracts and blanket purchase agreements. This contract award does not have a set-aside designation, reflecting Dakota Drug, Inc.'s established position as a reliable supplier to the DLA Troop Support Medical in support of comprehensive medical supply chain operations for the U.S. Department of Defense.

Generated 7/16/24, 12:38 PM